Skip to Content
Investing Specialists

Undervalued Stocks, Quarter-End Coverage, and Dividend Picks

We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended July 5.

Mentioned: , , ,

Inspired by Harper's Index (with a tip of the hat to FiveThirtyEight's Significant Digits blog), Morningstar Runs the Numbers uses a numbers-based approach to highlight recent Morningstar research.

The median stock in our coverage universe trades that much below fair value as of midyear. Energy remains the most undervalued sector, and we’re seeing compelling opportunities among the consumer cyclical sectors, too.

That’s how many undervalued stock picks our analysts have pulled together in their quarter-end reports.

That’s how much the mid-cap growth category gained in the second quarter, which was the best return among the domestic equity Morningstar Style Box categories.

Nearly $272,000
That’s how much you’d have today if you’d invested $100,000 in a good balanced fund a decade ago. Given the fine returns we’ve experienced during the past decade, Christine Benz suggests that investors avoid these four pitfalls.

That’s how many members comprise Dodge & Cox Stock’s (DODGX) investment committee. They’ve done an excellent job steering this contrarian gem.

That’s the dividend yield on  AT&T (T), one of six of our favorite stock ideas for dividend investors at midyear.

That’s how many steps are in Christine Benz’s midyear portfolio review.

8.7% vs. 7.8% 
That’s the annualized return of emerging-markets stocks and emerging-markets bonds, respectively, during the past 15 years. Despite the slight return edge, John Rekenthaler suggests that developing-markets bonds may be the better investment

That’s our fair value estimate on Nike (NKE). We think the company’s growth is on track.

About 14%
That’s the return of the MSCI EAFE Index. We take a look at international-stock fund performance in the second quarter.

That’s our fair value estimate of  CVS Health (CVS), which is among our top picks in the healthcare sector this quarter.

That’s how many easy ways there are to cut back on portfolio risk does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.